Sherer Renslow, Pulvirenti Joseph, Stieglitz Kim, Narra Jyothi, Jasek John, Green Lynn, Moore Billie, Shott Susan, Cohen Mardge
CORE Center, Cook County Hospital, Rush Medical College, Chicago, Illinois, USA.
J Int Assoc Physicians AIDS Care (Chic). 2002 Winter;1(1):26-33. doi: 10.1177/154510970200100106.
Reduction in HIV-related morbidity and mortality in the highly active antiretroviral therapy (HAART) era has been unevenly distributed in the United States, and its impact on hospitalizations in urban minority populations in the public sector has been poorly characterized.
We conducted a retrospective analysis of clinical and administrative data sets of an urban public hospital HIV clinic from 1997 and 1998 to identify the correlates of hospitalization early in the HAART era.
2,647 unduplicated HIV-infected patients were seen in 1997 and 1998 at the CORE Center. There were 31.7 percent women, 71 percent African-Americans and 12 percent Hispanics, and the mean age was 38 years. Men who had sex with men (MSM), injection drug users (IDU), and heterosexuals each made up one third of the population. A majority of the patients had no health insurance, and 27 percent had Medicaid. The median CD4 T cell count was 266 cells/microL, and the median viral load was 1,901 copies/ml. Hospitalizations declined significantly from 1997 (1,579) to 1998 (1,160). Admissions were confined to 25 percent of clinic patients, and 16 patients (range 8-15) had eight or more admissions. African-Americans and Hispanics had significantly more and longer hospitalizations than whites, but there was no difference by gender. IDUs had significantly more admissions than non-IDUs (28 percent vs. 21 percent respectively). On multivariate analysis, lower CD4 T cell count and higher viral load predicted risk of admission in all periods. Unexpectedly, hospitalization rates were high in patients in the highest baseline CD4 T cell stratum, > 500 cells/ml (45 of 353, 13 percent), and lowest viral load stratum, < 500 copies/ml (103 of 675, 15 percent), and rose from 1997 to 1998. HAART (i.e., 1 or 2 drug regimens) predicted fewer hospitalizations compared to 1 or 2 drug regimens. In a subset of patients who filled prescriptions on site, HAART increased from 72 percent to 85 percent and 1-2 drug regimens fell from 28 percent to 15 percent from 1997 to 1998. Regular care was associated with more frequent hospitalization and more hospital days per admission than no regular care. Hospitalized patients had significantly higher mortality than patients not hospitalized (12 percent vs. 2 percent respectively).
HIV-related hospitalizations were frequent in the HAART era and decreased over time. Older age, lack of HAART, lower CD4 T cell count, higher viral load, and minority race predicted hospitalization, while gender did not. However, patients with extremely favorable CD4 T cell and viral load counts also had higher than expected hospitalization rates. Three quarters of patients had no hospitalizations, and clustering of hospitalizations in a small number of patients may enable targeted programs to reduce recidivism.
在高效抗逆转录病毒治疗(HAART)时代,美国与艾滋病相关的发病率和死亡率的降低分布不均,其对公共部门城市少数族裔人群住院情况的影响尚未得到充分描述。
我们对一家城市公立医院艾滋病诊所1997年和1998年的临床和管理数据集进行了回顾性分析,以确定HAART时代早期住院的相关因素。
1997年和1998年,CORE中心共诊治了2647例未重复的艾滋病病毒感染患者。其中女性占31.7%,非裔美国人占71%,西班牙裔占12%,平均年龄为38岁。男同性恋者(MSM)、注射吸毒者(IDU)和异性恋者各占三分之一。大多数患者没有医疗保险,27%的患者有医疗补助。CD4 T细胞计数中位数为266个/微升,病毒载量中位数为1901拷贝/毫升。住院人数从1997年的1579例显著下降至1998年的1160例入院。入院患者仅占诊所患者的25%,16例患者(范围8 - 15例)入院8次或更多次。非裔美国人和西班牙裔的住院次数明显多于白人,住院时间也更长,但性别之间没有差异。注射吸毒者的入院次数明显多于非注射吸毒者(分别为28%和21%)。多因素分析显示,在所有时期,较低的CD4 T细胞计数和较高的病毒载量预示着入院风险。出乎意料的是,基线CD4 T细胞水平最高(>500个/毫升)的患者(353例中的45例,13%)和病毒载量最低(<500拷贝/毫升)的患者(675例中的103例,15%)的住院率也很高,且从1997年到1998年有所上升。与1或2种药物治疗方案相比,HAART(即1或2种药物治疗方案)预示着住院次数减少。在一部分在现场配药的患者中,1997年至1998年,接受HAART治疗的患者比例从72%增至85%,而接受1 - 2种药物治疗方案的患者比例从28%降至15%。与不定期就诊相比,定期就诊与更频繁的住院和每次入院更多的住院天数相关。住院患者的死亡率明显高于未住院患者(分别为12%和2%)。
在HAART时代,与艾滋病相关的住院情况很常见,且随时间推移有所减少。年龄较大、未接受HAART治疗、较低的CD4 T细胞计数、较高的病毒载量和少数族裔预示着住院,而性别则不然。然而,CD4 T细胞和病毒载量计数极为良好的患者的住院率也高于预期。四分之三的患者未住院,少数患者的住院聚集情况可能使针对性项目能够减少再入院率。